PhiChem Corporation (SHE:300398)
China · Delayed Price · Currency is CNY 27.04
-0.39 (-1.42%)
Oct 16, 2026, 3:04 PM CST
PhiChem Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 15,414 | 12,705 | 8,323 | 8,262 | 9,004 | 12,373 | |
Market Cap Growth | 11.10% | 52.65% | 0.74% | -8.24% | -27.23% | 36.52% |
Enterprise Value | 14,766 | 12,486 | 8,779 | 8,980 | 9,455 | 12,921 |
Last Close Price | 27.43 | 22.37 | 15.65 | 15.52 | 16.83 | 23.61 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 44.70 | 32.55 | 33.76 | 73.53 | 20.72 | 32.07 |
Forward PE | 26.12 | 32.96 | 22.84 | 19.37 | 19.35 | 33.61 |
PS Ratio | 4.85 | 3.94 | 2.85 | 3.03 | 3.10 | 4.71 |
PB Ratio | 3.10 | 2.52 | 2.00 | 2.09 | 2.36 | 3.81 |
P/TBV Ratio | 4.14 | 3.36 | 2.68 | 2.84 | 3.21 | 5.51 |
P/FCF Ratio | 89.21 | 72.49 | 20.11 | 433.44 | 44.50 | - |
P/OCF Ratio | 23.37 | 18.99 | 12.79 | 28.46 | 22.46 | 48.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 4.85 | 3.87 | 3.01 | 3.29 | 3.25 | 4.92 |
EV/EBITDA Ratio | 25.55 | 17.31 | 16.51 | 19.57 | 13.79 | 21.37 |
EV/EBIT Ratio | 37.95 | 25.13 | 25.27 | 31.92 | 17.50 | 26.72 |
EV/FCF Ratio | 85.51 | 71.23 | 21.21 | 471.13 | 46.73 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.15 | 0.15 | 0.37 | 0.44 | 0.45 | 0.52 |
Debt / EBITDA Ratio | 1.07 | 1.07 | 2.84 | 3.79 | 2.51 | 2.78 |
Debt / FCF Ratio | 4.45 | 4.45 | 3.67 | 92.03 | 8.55 | - |
Net Debt / Equity Ratio | -0.11 | -0.11 | 0.07 | 0.10 | 0.08 | 0.14 |
Net Debt / EBITDA Ratio | -0.76 | -0.76 | 0.53 | 0.90 | 0.46 | 0.78 |
Net Debt / FCF Ratio | -3.12 | -3.12 | 0.68 | 21.54 | 1.56 | -43.49 |
Asset Turnover | 0.48 | 0.48 | 0.45 | 0.43 | 0.48 | 0.46 |
Inventory Turnover | 3.05 | 3.05 | 2.92 | 2.58 | 2.51 | 2.70 |
Quick Ratio | 1.66 | 1.66 | 1.42 | 1.60 | 1.47 | 1.25 |
Current Ratio | 2.18 | 2.18 | 1.85 | 2.04 | 1.95 | 1.69 |
Return on Equity (ROE) | 8.86% | 8.86% | 6.72% | 3.50% | 12.55% | 13.00% |
Return on Assets (ROA) | 4.57% | 4.57% | 3.32% | 2.75% | 5.55% | 5.30% |
Return on Invested Capital (ROIC) | 9.36% | 9.64% | 7.05% | 5.95% | 12.38% | 11.67% |
Return on Capital Employed (ROCE) | 9.20% | 9.20% | 7.20% | 5.80% | 11.80% | 11.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 2.50% | 3.07% | 2.96% | 1.36% | 4.83% | 3.12% |
FCF Yield | 1.12% | 1.38% | 4.97% | 0.23% | 2.25% | -0.09% |
Dividend Yield | 0.43% | - | 0.60% | 0.51% | 0.47% | 0.29% |
Payout Ratio | 21.79% | 21.80% | 36.64% | 80.58% | 18.69% | 20.06% |
Buyback Yield / Dilution | -4.83% | -4.83% | 1.96% | -3.42% | -0.56% | -0.73% |
Total Shareholder Return | -4.41% | -4.83% | 2.56% | -2.90% | -0.09% | -0.44% |